Recent Finacing
Recent Raise
X-Vax Technology is a biotech developing mucosal vaccines, primarily ∆gD-2, a gD-deleted HSV vaccine that elicits Fc receptor-activating antibodies mediating ADCK and has preclinical protection against HSV-1/2.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at X-Vax Technology.
